Death | ||||
---|---|---|---|---|
PTH change group | Unadjusted | Adjusted | ||
All patients | HR (95% CI) | P | HR (95% CI) | P |
No PTH reduction | 1.15 (0.89-1.49) | 0.3 | 1.23 (0.94-1.61) | 0.1 |
Quartile 1 | Referent | Referent | ||
Quartile 2 | 1.06 (0.79-1.42) | 0.7 | 1.05 (0.78-1.41) | 0.8 |
Quartile 3 | 1.01 (0.75-1.36) | 0.9 | 0.95 (0.71-1.29) | 0.7 |
Quartile 4 | 1.20 (0.91-1.60) | 0.2 | 1.03 (0.77-1.39) | 0.8 |
Baseline PTH 300-600 pg/mL | ||||
No PTH reduction | 0.98 (0.67-1.43) | 0.9 | 1.05 (0.70-1.55) | 0.8 |
Quartile 1 | Referent | Referent | ||
Quartile 2 | 1.06 (0.69-1.62) | 0.8 | 1.09 (0.70-1.69) | 0.7 |
Quartile 3 | 1.08 (0.71-1.65) | 0.7 | 0.98 (0.63-1.52) | 0.9 |
Quartile 4 | 1.06 (0.69-1.63) | 0.8 | 0.92 (0.59-1.44) | 0.7 |
Baseline PTH > 600 pg/mL | ||||
No PTH reduction | 1.36 (0.95-1.94) | 0.1 | 1.47 (1.02-2.13) | 0.04 |
Quartile 1 | Referent | Referent | ||
Quartile 2 | 1.06 (0.71-1.59) | 0.8 | 1.04 (0.69-1.56) | 0.9 |
Quartile 3 | 0.95 (0.63-1.43) | 0.8 | 0.90 (0.59-1.37) | 0.6 |
Quartile 4 | 1.32 (0.91-1.94) | 0.2 | 1.16 (0.78-1.73) | 0.5 |